Homann Carl N, Homann Barbara, Ivanic Gerd, Urbanic-Purkart Tadea
Department of Neurology, Medical University Graz, Graz, Austria.
St. Elizabeth University of Health and Social Work, Bratislava, Slovakia.
Front Aging Neurosci. 2024 Jan 26;16:1333217. doi: 10.3389/fnagi.2024.1333217. eCollection 2024.
Nutrition plays a pivotal role in the multidisciplinary approach to rehabilitating middle to old-aged patients with neurological diseases including movement disorders (MDs). Despite the prevalence of vitamin D deficiency in many patients with MDs, data supporting supplementation's effectiveness and safety is sparse and conflicting, therefore, our explicit objective was to provide an all-encompassing review of the subject.
A comprehensive search of PubMed, Embase, and other scientific databases was conducted up to November 1 2023. The searches included RCTs in all languages with human participants aged 35 and above and not meeting these requirements led to exclusion.
Four studies on Parkinson's disease (PD) and one on restless legs syndrome (RLS) including 369 MD patients, however, none in a rehabilitation context, were found. Although three of the four PD studies showed better outcomes, such as decreasing levodopa-induced dyskinesia or enhancing physical performance in some or all domains, the RLS study did not identify symptom improvement. The one serious adverse effect observed, cerebral infarction, aroused safety concerns, however its relationship to vitamin D consumption is questionable. Structurally the studies can be characterized by large variations in patient populations, in primary outcomes, and disease severity, but typically a relatively short duration of therapy in most cases. With other limitations such as the small number of studies, major trial design heterogeneity, limited sample sizes, and a greatly variable Cochrane risk of bias (RoB) evaluation, only a qualitative synthesis was feasible.
Two main implications can be inferred from these results, which we interpret as cautiously promising but overall insufficient for firm recommendations. First, there is an urgent need for more research on the role of vitamin D in MDs in the middle- to older-aged population, particularly during rehabilitation. Second, given the benefits of vitamin D supplementation for those who are deficient, we recommend routine screening and supplementation for MD patients.
营养在多学科方法康复中老年神经系统疾病患者(包括运动障碍患者)中起着关键作用。尽管许多运动障碍患者普遍存在维生素D缺乏的情况,但支持补充维生素D有效性和安全性的数据却稀少且相互矛盾,因此,我们的明确目标是对该主题进行全面综述。
截至2023年11月1日,对PubMed、Embase和其他科学数据库进行了全面检索。检索包括所有语言的随机对照试验,参与者年龄在35岁及以上,不符合这些要求的则被排除。
发现了四项关于帕金森病(PD)的研究和一项关于不安腿综合征(RLS)的研究,共涉及369名运动障碍患者,但均未涉及康复背景。虽然四项PD研究中有三项显示出更好的结果,如减少左旋多巴引起的运动障碍或在某些或所有领域提高身体表现,但RLS研究未发现症状改善。观察到的一项严重不良反应是脑梗死,这引发了安全担忧,但其与维生素D摄入的关系尚存在疑问。从结构上看,这些研究的特点是患者群体、主要结局和疾病严重程度差异很大,但大多数情况下治疗持续时间相对较短。由于存在研究数量少、主要试验设计异质性、样本量有限以及Cochrane偏倚风险(RoB)评估差异很大等其他局限性,仅进行定性综合分析是可行的。
从这些结果可以推断出两个主要结论,我们认为这谨慎地显示出前景,但总体上不足以做出确凿的推荐。第一,迫切需要更多关于维生素D在中老年运动障碍患者中的作用的研究,特别是在康复期间。第二,鉴于补充维生素D对缺乏维生素D者有益,我们建议对运动障碍患者进行常规筛查和补充。